Secondary mania: diagnosis and treatment

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Bipolar disorder subtypes exhibit distinct clinical features, onset ages, illness courses, and treatment responses.
• Secondary manic states, arising from organic factors, present unique treatment challenges compared to typical bipolar disorder.
• Reversible organic causes of mania can be treated, but irreversible factors like stroke or aging complicate management.

Purpose of the Study:

• To review the treatment of secondary mania, focusing on challenges and alternative therapies.
• To evaluate the efficacy and tolerability of anticonvulsants, specifically divalproex sodium, in secondary mania.

Main Methods:

• Literature review of studies on secondary mania treatments.
• Analysis of clinical trial data for lithium and anticonvulsants in secondary mania populations.
• Focus on patient groups with irreversible organic etiologies and the elderly.

Main Results:

• Lithium's efficacy in secondary mania is often limited by adverse effects in this population.
• Anticonvulsants, particularly divalproex sodium, show promise as effective and well-tolerated treatments.
• Open trials suggest divalproex sodium is effective and tolerated in elderly patients and others with secondary mania.

Conclusions:

• Divalproex sodium represents a potentially effective and well-tolerated alternative for managing secondary mania.
• Mood-stabilizing anticonvulsants warrant further investigation for secondary mania treatment.
• Controlled clinical trials are essential to confirm the efficacy and tolerability of anticonvulsants in secondary mania.